Back to Browse Journals » Breast Cancer: Targets and Therapy » Volume 3

Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer

Authors Menis J, Twelves C

Published 26 August 2011 Volume 2011:3 Pages 101—111


Review by Single-blind

Peer reviewer comments 2

J Menis1, C Twelves2
1Department of Oncology, University Hospital Santa Maria della Misericordia, Udine, Italy; 2Leeds Cancer Research UK Centre, University of Leeds and St James's Institute of Oncology, Leeds, UK

Abstract: Although metastatic breast cancer remains essentially incurable, many patients previously treated with an anthracycline, taxane, and capecitabine are relatively fit and keen to receive further therapy. Several drugs are used in this setting, but with little evidence of clinically relevant benefit, and none have previously shown improved survival. Eribulin (Halaven®) is a nontaxane tubulin-binding agent with a novel mode of action, and was recently approved by the European Medicines Agency and US Food and Drug Agency as a single agent for patients with heavily pretreated metastatic breast cancer. This review provides an overview of the discovery, and preclinical and clinical development of eribulin, culminating in the recently published EMBRACE metastatic breast cancer study.

Keywords: eribulin, metastatic breast cancer, pretreated

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Triple negative breast cancer: an Indian perspective

Akhtar M, Dasgupta S, Rangwala M

Breast Cancer: Targets and Therapy 2015, 7:239-243

Published Date: 14 August 2015

Major affective disorders in chronic obstructive pulmonary disease compared with other chronic respiratory diseases

Pothirat C, Chaiwong W, Phetsuk N, Pisalthanapuna S, Chetsadaphan N, Inchai J

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1583-1590

Published Date: 7 August 2015

Palliative care in COPD: an unmet area for quality improvement

Vermylen JH, Szmuilowicz E, Kalhan R

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1543-1551

Published Date: 6 August 2015

Cardiac risk in the treatment of breast cancer: assessment and management

Valachis A, Nilsson C

Breast Cancer: Targets and Therapy 2015, 7:21-35

Published Date: 16 January 2015

Synthesis, pharmacokinetics, and biological use of lysine-modified single-walled carbon nanotubes [Erratum]

Mulvey JJ, Feinberg EN, Alidori S, McDevitt MR, Heller DA, Scheinberg DA

International Journal of Nanomedicine 2015, 10:595-596

Published Date: 14 January 2015

Variability in contrast agent uptake by different but similar stem cell types

Ketkar-Atre A, Struys T, Soenen SJ, Lambrichts I, Verfaillie CM, De Cuyper M, Himmelreich U

International Journal of Nanomedicine 2013, 8:4577-4591

Published Date: 29 November 2013

The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes

Tsikripis P, Papaconstantinou D, Koutsandrea C, Apostolopoulos M, Georgalas I

Drug Design, Development and Therapy 2013, 7:1149-1156

Published Date: 4 October 2013

Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo

Qiao C, Zhang K, Jin H, Miao L, Shi C, Liu X, Yuan A, Liu J, Li D, Zheng C, Zhang G, Li X, Yang B, Sun H

International Journal of Nanomedicine 2013, 8:2985-2995

Published Date: 13 August 2013

Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer

Gao X, Wang BL, Wei XW, Rao W, Ai F, Zhao F, Men K, Yang BW, Liu XY, Huang MJ, Gou ML, Qian ZY, Huang N, Wei YQ

International Journal of Nanomedicine 2013, 8:971-982

Published Date: 8 March 2013

Fabrication and characterization of graphene hydrogel via hydrothermal approach as a scaffold for preliminary study of cell growth

Lim HN, Huang NM, Lim SS, Harrison I, Chia CH

International Journal of Nanomedicine 2011, 6:1817-1823

Published Date: 30 August 2011